Developing a Myc inhibitor to treat cancer Peptomyc is a company focused on the development of a new generation of cell penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment. The company was founded in December 2014 and it is based on Dr. Soucek’s scientific research in Omomyc (the best direct Myc inhibitor
http://www.peptomyc.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Wednesday
LOAD TIME
4 seconds
PAGES IN
THIS WEBSITE
6
SSL
EXTERNAL LINKS
2
SITE IP
93.174.3.50
LOAD TIME
4 sec
SCORE
6.2
Peptomyc | peptomyc.com Reviews
https://peptomyc.com
Developing a Myc inhibitor to treat cancer Peptomyc is a company focused on the development of a new generation of cell penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment. The company was founded in December 2014 and it is based on Dr. Soucek’s scientific research in Omomyc (the best direct Myc inhibitor
peptomyc.com
Peptomyc - Team
http://www.peptomyc.com/team
Scientific Advisory Board (SAB). Co-Founder and Chief Executive Officer (CEO) of Peptomyc S.L. Principal Investigator of the Mouse Models of Cancer Therapies Group at the Vall d Hebron Institute of Oncology (VHIO) and ICREA Professor. Soucek, L., Helmer-Citterich, M., Sacco, A., Jucker, R., Cesareni, G., and Nasi, S. (1998). Oncogene 17, 2463-2472. Soucek, L., Jucker, R., Panacchia, L., Ricordy, R., Tato, F., and Nasi, S. (2002). Cancer Research 62, 3507-3510. Co-Founder and Chief Scientific Officer (CSO...
Peptomyc - peptomyc_2015
http://www.peptomyc.com/author/peptomyc_2015
Scientific Advisory Board (SAB). This author has not yet filled in any details. So far peptomyc 2015 has created 7 blog entries. Peptomyc receives 850K from Spanish Mineco and European Commission joint fund. 30 / 11 / 16. Peptomyc wins prize at EIT Health Summit. Barcelona 23-24th November 2016. A highlight of the event was the Business Plan Aggregator Competition. 21 start-ups pitched their […]. 23 / 11 / 16. Such Briefing Meetings provide a forum for early dialogue covering regulatory, technical and sc...
Peptomyc - Scientific Advisory Board (SAB)
http://www.peptomyc.com/scientific-advisory-board-sab
Scientific Advisory Board (SAB). Scientific Advisory Board (SAB). Scientific Advisory Board (SAB). Scientific Advisory Board (SAB). Peptomyc S.L. benefits from the expertise of a strong Scientific Advisory Board (SAB). Comprising the following internationally renowned thought leaders in oncology:. Head of the Medical Oncology Department of the Vall d’Hebron University Hospital; Director of the Vall d’Hebron Institute of Oncology, Barcelona, Spain. Professor and Chairman, Department of Oncology. Universit...
Peptomyc - Partners
http://www.peptomyc.com/partners
Scientific Advisory Board (SAB). The Vall d Hebron Institute of Oncology (VHIO). The Vall d Hebron Institute of Oncology (VHIO). Established in 2006, VHIO is a leading comprehensive cancer center of excellence where its researchers and physician-scientists adopt a purely translational research model, working together as multidisciplinary teams to both accelerate and advance personalized and targeted therapies against cancer. HealthEquity is a Spanish venture capital firm investing in early-stage companie...
Peptomyc - Investors
http://www.peptomyc.com/investors
Scientific Advisory Board (SAB). Peptomyc’s business model consists of de-risking Omomyc-CPP from a Proof of Concept Development Stage into a successful Phase I/II product and then Licensing it to a Pharmaceutical company. Peptomyc is currently looking for investors in order to fund the pre-clinical development of Omomyc. Should you have any enquiries please contact lsoucek@peptomyc.com. Peptomyc receives 850K from Spanish Mineco and European Commission joint fund. Peptomyc wins prize at EIT Health Summit.
TOTAL PAGES IN THIS WEBSITE
6
healthequity
http://www.healthequity.es/index.html
A través de la innovación. Healthequity es una sociedad de capital riesgo especializada en proyectos early-stage del sector salud: dispositivos médicos, biotecnología y servicios sanitarios. Es un fondo promovido por el Colegio Oficial de Médicos de Barcelona y el grupo financiero Riva y Garcia que está buscando proyectos para realizar sus primeras inversiones. Healthequity fue registrado en la CNMV y fundado en el año 2012. Fondo financiado por FEDER. El objetivo de Healthequity es diversificar riesgos,...
---- healthequity ----
http://www.healthequity.es/index_eng.html
Healthequity is a VC fund focused on investing in early-stage companies in the Healthcare sector: Biotechnology, medical devices and healthcare services. Promoted by the Medical Association of Barcelona and the financial group Riva y Garcia, HealthEquity is looking for projects to make its first investments. Healthequity was registered with the CNMV and founded in 2012. Fund financed by FEDER. The aim is to diversify risk, making companies coexist in different stages of maturation and in different sub-se...
TOTAL LINKS TO THIS WEBSITE
2
Graphic design, Website design and identity design. Melbourne, Australia
PeptoLab - Design is a pleasure. Design is a pleasure. Our site is being refreshed and renewed. A brand new look at our work will be available in October. Simon Mundy 61 438 046 061. Lvl 2 / 41 A'Beckett Street. What we’re known for. Who we work with. Design, User Interface. Design, User Interface. Ararat Rural City Council. Branding, Design, Website. Branding, Design, Website, Corporate Literature. Design, Website, eCommerce. Edwards Dunlop / CPI Paper. Design by Design by Pidgeon. Reactive installation...
Genostim
PEPTOMICS - MOLECULAR WORD MODELLING
A METHOD TO EXTRACT. WORDS OUT OF PROTEINS. The basis of the project is the fact that proteins in cells are defined by a sequence of letters. The project team has developed a unique method, which extracts letter combinations from proteins. On the right you can see the visualization of the seven sins. Each sin can be digested. We found the proteins containing (the words of) the seven sins within the human genome. INFO PDF (1.4 MB).
Procter & Gamble
Peptomyc
Scientific Advisory Board (SAB). Developing a Myc inhibitor to treat cancer. Peptomyc is a company focused on the development of a new generation of cell penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment. The company was founded in December 2014 and it is based on Dr. Soucek’s scientific research in Omomyc (the best direct Myc inhibitor known to date) over the last twenty years. Rationale and market opportunity. Scientific Advisory Board (SAB).
Revitalización y Nutrición Biológica | Laboratorio Linfar
Linfar - La vida avanza. Qué son las Peptonas? E Casas Ocampo 2833, Altos de San Martín. X5009CRA, Córdoba, Argentina. Tel / Fax: 54 351 4815786. Desde el interior del país: 0810 55 LINFAR (546327).
Online inhibitor | papers about inhibitor
Br Conflict of interest br Acknowledgments br Introduction Electronic. April 13, 2018. Almost all students reported that they Stem Cell Compound Library had. In our study, experimentation with e-cigarettes was more frequent among smokers compared with non-smokers and among males compared with females. As smoking among females is culturally unacceptable and considered taboo in Saudi Arabia, we expected that e-cigarettes would be less popular among female participants. These findings are similar to...The s...
peptone in a sentence | simple examples
In A Sentence .org. The best little site that helps you understand word usage with examples. Peptone in a sentence. Is it pepsin , the active principle of the gastric juice, which converts proteids into peptone, that is wanting, or is there a deficiency of pancreatin? With weaker doses of antigen and with antigens that are harmless or practically so, such as peptone, the anaphylactic leucocytosis does not last as long but is nevertheless pronounced. Use bravoes in a sentence. Use deludingly in a sentence.
